{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:02:34Z","timestamp":1789383754734,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"DOI":"10.1007\/s12602-026-11134-3","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:03:08Z","timestamp":1789376588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unveiling the Gastric Microbiome: Novel Insights into Early Detection and Pathogenesis of Gastric Cancer"],"prefix":"10.1007","author":[{"given":"Suresh","family":"Malchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kodiganti Naresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreekanthyadav","family":"Pokala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathish Kumar","family":"Venkatachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthasarathy","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nallusamy","family":"Duraisamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"issue":"1","key":"11134_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s13402-024-00965-3","volume":"48","author":"B Wang","year":"2025","unstructured":"Wang B, Luan J, Zhao W, Yu J, Li A, Li X, Zhong X, Cao H, Wang R, Liu B (2025) Comprehensive multiomics analysis of the signatures of gastric mucosal bacteria and plasma metabolites across different stomach microhabitats in the development of gastric cancer. Cell Oncol 48(1):139\u2013159","journal-title":"Cell Oncol"},{"issue":"1","key":"11134_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s44342-024-00001-8","volume":"22","author":"AR Nath","year":"2024","unstructured":"Nath AR, Natarajan J (2024) Gut metagenomic analysis of gastric cancer patients reveals Akkermansia, Gammaproteobacteria, and Veillonella microbiota as potential non-invasive biomarkers. Genomics Inf 22(1):1","journal-title":"Genomics Inf"},{"key":"11134_CR3","doi-asserted-by":"publisher","first-page":"1105811","DOI":"10.3389\/fcimb.2022.1105811","volume":"12","author":"Y Guo","year":"2023","unstructured":"Guo Y, Cao X-S, Zhou M-G, Yu B (2023) Gastric microbiota in gastric cancer: different roles of Helicobacter pylori and other microbes. Front Cell Infect Microbiol 12:1105811","journal-title":"Front Cell Infect Microbiol"},{"key":"11134_CR4","doi-asserted-by":"crossref","unstructured":"Wang B, Luan J, Zhao W, bao Yu J, Li A, Li X, Zhong X, Cao H, Wang R, Liu B (2023) Analysis of gastric mucosal commensal bacteria and plasma metabolites across different stomach microhabitats using multi-omic analyses in development of gastric cancer","DOI":"10.21203\/rs.3.rs-3078610\/v1"},{"key":"11134_CR5","doi-asserted-by":"crossref","unstructured":"Giddings HJ, Teod\u00f3sio A, McMurray JL, Hunter K, Abdawn Z, Cole JA, Shannon-Lowe CD, Rossiter-Pearson AE, The gatekeeper to gastriccancer; gastric microbiota invade the lamina propria in Helicobacter pylori-associated gastric carcinogenesis, bioRxiv 2024.04. 22.590522.","DOI":"10.1101\/2024.04.22.590522"},{"issue":"5","key":"11134_CR6","doi-asserted-by":"publisher","first-page":"e0401223","DOI":"10.1128\/spectrum.04012-23","volume":"12","author":"M Gao","year":"2024","unstructured":"Gao M, Wu J, Zhou S, Chen Y, Wang M, He W, Jiang L, Shu Y, Wang X (2024) Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma. Microbiol Spectr 12(5):e0401223","journal-title":"Microbiol Spectr"},{"key":"11134_CR7","doi-asserted-by":"publisher","first-page":"217456","DOI":"10.1016\/j.canlet.2025.217456","volume":"612","author":"P Li","year":"2025","unstructured":"Li P, Zhang H, Chen L, Gao X, Hu Y, Xu Q, Liu W, Chen W, Chen H, Yuan S, Wang M, Liu S, Dai M (2025) Oral and fecal microbiota as accurate non-invasive tools for detection of pancreatic cancer in the Chinese population. Cancer Lett 612:217456","journal-title":"Cancer Lett"},{"key":"11134_CR8","doi-asserted-by":"publisher","first-page":"1658693","DOI":"10.3389\/fmicb.2025.1658693","volume":"16","author":"Z Wu","year":"2025","unstructured":"Wu Z, Zhu Z, Zhou C, Lin Z, Yang H, Jiang G, Ding S, Yu J, Sun L (2025) Stage-specific fecal and salivary microbiota signatures for noninvasive detection of colorectal cancer. Front Microbiol 16:1658693","journal-title":"Front Microbiol"},{"issue":"12","key":"11134_CR9","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1136\/gutjnl-2024-332815","volume":"73","author":"R Zeng","year":"2024","unstructured":"Zeng R, Gou H, Lau HCH, Yu J (2024) Stomach microbiota in gastric cancer development and clinical implications. Gut 73(12):2062\u20132073","journal-title":"Gut"},{"key":"11134_CR10","doi-asserted-by":"publisher","first-page":"1218395","DOI":"10.3389\/fmicb.2023.1218395","volume":"14","author":"H Huang","year":"2023","unstructured":"Huang H, Zhong W, Wang X, Yang Y, Wu T, Chen R, Liu Y, He F, Li J (2023) The role of gastric microecological dysbiosis in gastric carcinogenesis. Front Microbiol 14:1218395","journal-title":"Front Microbiol"},{"key":"11134_CR11","doi-asserted-by":"publisher","unstructured":"Bintintan V, Burz C, Pintea I, Muntean A, Deleanu D, Lupan I, Samasca G (2024) The importance of extracellular vesicle screening in gastric cancer: a 2024 update. Cancers (Basel) 16(14):2574. https:\/\/doi.org\/10.3390\/cancers16142574","DOI":"10.3390\/cancers16142574"},{"issue":"35","key":"11134_CR12","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.3748\/wjg.v30.i35.3972","volume":"30","author":"V Petkevicius","year":"2024","unstructured":"Petkevicius V, Lehr K, Kupcinskas J, Link A (2024) Fusobacterium nucleatum: Unraveling its potential role in gastric carcinogenesis. World J Gastroenterol 30(35):3972\u20133984","journal-title":"World J Gastroenterol"},{"key":"11134_CR13","doi-asserted-by":"crossref","unstructured":"Begum H, Ashu EE, Nippak P (2024) Emerging trends and potential clinical applications of microbial biomarkers in thoracic surgery. Curr Challenges Thorac Surg 6:25","DOI":"10.21037\/ccts-24-17"},{"key":"11134_CR14","doi-asserted-by":"publisher","first-page":"1571341","DOI":"10.3389\/fcimb.2025.1571341","volume":"15","author":"X Tong","year":"2025","unstructured":"Tong X, Chen X, Shen C, Pan J, Wang X, Xu X, Liu S (2025) Integrated analysis of microbiome and host transcriptome revealed correlations between tissue microbiota and tumor progression in early-stage papillary thyroid carcinoma. Front Cell Infect Microbiol 15:1571341","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"11134_CR15","doi-asserted-by":"publisher","first-page":"e70115","DOI":"10.1111\/1751-7915.70115","volume":"18","author":"Y Wang","year":"2025","unstructured":"Wang Y, Qiu X, Chu A, Chen J, Wang L, Sun X, Wang B, Yuan Y, Gong Y (2025) Advances in 16S rRNA-Based Microbial Biomarkers for Gastric Cancer Diagnosis and Prognosis. Microb Biotechnol 18(2):e70115","journal-title":"Microb Biotechnol"},{"issue":"3","key":"11134_CR16","first-page":"537","volume":"29","author":"J Puerta-Su\u00e1rez","year":"2025","unstructured":"Puerta-Su\u00e1rez J, Maya WDC (2025) Is Lactobacillus spp. beneficial in human semen? Systematic review. JBRA Assist Reprod 29(3):537\u2013547","journal-title":"JBRA Assist Reprod"},{"key":"11134_CR17","doi-asserted-by":"publisher","unstructured":"Szklenarik G, Kiraly P, Szegvari G, Dora D, Lohinai Z (2024) Predicting cancer-related mycobiome aspects in gastrointestinal cancers: a systematic review. Front Med 11:1488377. https:\/\/doi.org\/10.3389\/fmed.2024.1488377","DOI":"10.3389\/fmed.2024.1488377"},{"key":"11134_CR18","doi-asserted-by":"publisher","unstructured":"Mohamed AS, Bhuju R, Martinez E, Basta M, Deyab A, Mansour C, Tejada D, Deshpande V, Elias S, Nagesh VK (2025) The gut microbiome\u2019s impact on the pathogenesis and treatment of gastric cancer-an updated literature review. Cancers (Basel) 17(17):2795. https:\/\/doi.org\/10.3390\/cancers17172795","DOI":"10.3390\/cancers17172795"},{"key":"11134_CR19","doi-asserted-by":"publisher","unstructured":"Bautista J, Maldonado-Noboa I, Maldonado-Guerrero D, Reinoso-Quinga L, L\u00f3pez-Cort\u00e9s A (2025) Microbiome influence in gastric cancer progression and therapeutic strategies. Front Med 12:1681824. https:\/\/doi.org\/10.3389\/fmed.2025.1681824","DOI":"10.3389\/fmed.2025.1681824"},{"issue":"1","key":"11134_CR20","first-page":"3","volume":"3","author":"D Sharma","year":"2024","unstructured":"Sharma D, Gajjar D, Seshadri S (2024) Understanding the role of gut microfloral bifidobacterium in cancer and its potential therapeutic applications. Microbiome Res Rep 3(1):3","journal-title":"Microbiome Res Rep"},{"issue":"1","key":"11134_CR21","doi-asserted-by":"publisher","first-page":"16240","DOI":"10.1038\/s41598-020-73448-8","volume":"10","author":"ET Boehm","year":"2020","unstructured":"Boehm ET, Thon C, Kupcinskas J, Steponaitiene R, Skieceviciene J, Canbay A, Malfertheiner P, Link A (2020) Fusobacterium nucleatum is associated with worse prognosis in Lauren\u2019s diffuse type gastric cancer patients. Sci Rep 10(1):16240","journal-title":"Sci Rep"},{"issue":"1","key":"11134_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s44342-024-00001-8","volume":"22","author":"AR Nath","year":"2024","unstructured":"Nath AR, Natarajan J (2024) Gut metagenomic analysis of gastric cancer patients reveals Akkermansia, Gammaproteobacteria, and Veillonella microbiota as potential non-invasive biomarkers. Genomics Inf 22(1):1","journal-title":"Genomics Inf"},{"issue":"3","key":"11134_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jshs.2020.03.002","volume":"9","author":"AD Kostic","year":"2020","unstructured":"Kostic AD (2020) Reply to Is physical performance (in mice) increased by Veillonella atypica or decreased by Lactobacillus bulgaricus? J Sport Health Sci 9(3):201\u2013202","journal-title":"J Sport Health Sci"},{"key":"11134_CR24","doi-asserted-by":"publisher","first-page":"1652702","DOI":"10.3389\/fmicb.2025.1652702","volume":"16","author":"X He","year":"2025","unstructured":"He X, Zhao Q, Zhang J, Shi J, Wan N, Tang B, Tian B, Li P (2025) Potential and application of Fusobacterium nucleatum in the diagnosis and treatment of colorectal cancer. Front Microbiol 16:1652702","journal-title":"Front Microbiol"},{"issue":"1","key":"11134_CR25","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12935-021-01886-z","volume":"21","author":"M Ranjbar","year":"2021","unstructured":"Ranjbar M, Salehi R, Haghjooy Javanmard S, Rafiee L, Faraji H, Jafarpor S, Ferns GA, Ghayour-Mobarhan M, Manian M, Nedaeinia R (2021) The dysbiosis signature of Fusobacterium nucleatum in colorectal cancer-cause or consequences? A systematic review. Cancer Cell Int 21(1):194","journal-title":"Cancer Cell Int"},{"issue":"6","key":"11134_CR26","doi-asserted-by":"publisher","first-page":"106847","DOI":"10.5306\/wjco.v16.i6.106847","volume":"16","author":"D Wang","year":"2025","unstructured":"Wang D, Zhang HL, Zhang HL, Song ZJ, Doblin S, Lu P (2025) Microbiota and cancer: Elucidating the role of Candida albicans in cancer progression. World J Clin Oncol 16(6):106847","journal-title":"World J Clin Oncol"},{"key":"11134_CR27","doi-asserted-by":"publisher","first-page":"1412709","DOI":"10.3389\/fmed.2024.1412709","volume":"11","author":"A Marashi","year":"2024","unstructured":"Marashi A, Hasany S, Moghimi S, Kiani R, Mehran Asl S, Dareghlou YA, Lorestani P, Varmazyar S, Jafari F, Ataeian S, Naghavi K, Sajjadi SM, Haratian N, Alinezhad A, Azhdarimoghaddam A, Sadat SK, Rafiei MA, Anar (2024) Targeting gut-microbiota for gastric cancer treatment: a systematic review. Front Med (Lausanne) 11:1412709","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"11134_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s42764-020-00010-1","volume":"1","author":"X Liu","year":"2020","unstructured":"Liu X, Irfan M, Xu X, Tay C-Y, Marshall BJ (2020) Helicobacter pylori infection induced genome instability and gastric cancer. Genome Instability Disease 1(3):129\u2013142","journal-title":"Genome Instability Disease"},{"issue":"4","key":"11134_CR29","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1097\/MS9.0000000000001802","volume":"86","author":"Y Gu","year":"2024","unstructured":"Gu Y, Xu Y, Wang P, Zhao Y, Wan C (2024) Research progress on molecular mechanism of pyroptosis caused by Helicobacter pylori in gastric cancer. Annals Med Surg 86(4):2016\u20132022","journal-title":"Annals Med Surg"},{"issue":"1","key":"11134_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13045-024-01654-2","volume":"18","author":"Y Duan","year":"2025","unstructured":"Duan Y, Xu Y, Dou Y, Xu D (2025) Helicobacter pylori and gastric cancer: mechanisms and new perspectives. J Hematol Oncol 18(1):10","journal-title":"J Hematol Oncol"},{"issue":"1","key":"11134_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13045-024-01654-2","volume":"18","author":"Y Duan","year":"2025","unstructured":"Duan Y, Xu Y, Dou Y, Xu D (2025) Helicobacter pylori and gastric cancer: mechanisms and new perspectives. J Hematol Oncol 18(1):10","journal-title":"J Hematol Oncol"},{"issue":"1","key":"11134_CR32","doi-asserted-by":"publisher","first-page":"2314201","DOI":"10.1080\/19490976.2024.2314201","volume":"16","author":"SC Tran","year":"2024","unstructured":"Tran SC, Bryant KN, Cover TL (2024) The Helicobacter pylori cag pathogenicity island as a determinant of gastric cancer risk. Gut Microbes 16(1):2314201","journal-title":"Gut Microbes"},{"issue":"1","key":"11134_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41423-019-0339-5","volume":"17","author":"A Takahashi-Kanemitsu","year":"2020","unstructured":"Takahashi-Kanemitsu A, Knight CT, Hatakeyama M (2020) Molecular anatomy and pathogenic actions of Helicobacter pylori CagA that underpin gastric carcinogenesis. Cell Mol Immunol 17(1):50\u201363","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"11134_CR34","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1111\/cas.13332","volume":"108","author":"H Kitamura","year":"2017","unstructured":"Kitamura H, Ohno Y, Toyoshima Y, Ohtake J, Homma S, Kawamura H, Takahashi N, Taketomi A (2017) Interleukin-6\/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy. Cancer Sci 108(10):1947\u20131952","journal-title":"Cancer Sci"},{"issue":"2","key":"11134_CR35","doi-asserted-by":"publisher","first-page":"107052","DOI":"10.4291\/wjgp.v16.i2.107052","volume":"16","author":"Y Raza","year":"2025","unstructured":"Raza Y, Mubarak M, Memon MY, Alsulaimi MS (2025) Update on molecular pathogenesis of Helicobacter pylori-induced gastric cancer. World J Gastrointest Pathophysiol 16(2):107052","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"1","key":"11134_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12964-015-0111-0","volume":"13","author":"X Yong","year":"2015","unstructured":"Yong X, Tang B, Li B-S, Xie R, Hu C-J, Luo G, Qin Y, Dong H, Yang S-M (2015) Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways. Cell communication Signal 13(1):30","journal-title":"Cell communication Signal"},{"issue":"1","key":"11134_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12029-020-00518-5","volume":"52","author":"M Alipour","year":"2021","unstructured":"Alipour M (2021) Molecular Mechanism of Helicobacter pylori-Induced Gastric Cancer. J Gastrointest Cancer 52(1):23\u201330","journal-title":"J Gastrointest Cancer"},{"issue":"1","key":"11134_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41420-025-02289-z","volume":"11","author":"X Cui","year":"2025","unstructured":"Cui X, Chang M, Wang Y, Liu J, Sun Z, Sun Q, Sun Y, Ren J, Li W (2025) Helicobacter pylori reduces METTL14-mediated VAMP3 m6A modification and promotes the development of gastric cancer by regulating LC3C-mediated c-Met recycling. Cell Death Discovery 11(1):13","journal-title":"Cell Death Discovery"},{"key":"11134_CR39","doi-asserted-by":"publisher","unstructured":"Sharafutdinov I, Tegtmeyer N, Linz B, Rohde M, Vieth M, Tay A, Lamichhane B, Tuan V, Fauzia K, Sticht H, Yamaoka Y, Marshall B, Backert S (2023) A single-nucleotide polymorphism in Helicobacter pylori promotes gastric cancer development. Cell Host Microbe 31(8):1345\u20131358. https:\/\/doi.org\/10.1016\/j.chom.2023.06.016","DOI":"10.1016\/j.chom.2023.06.016"},{"key":"11134_CR40","doi-asserted-by":"publisher","unstructured":"Doohan D, Rezkitha YAA, Waskito LA, Yamaoka Y, Miftahussurur M (2021) Helicobacter pylori BabA-SabA key roles in the adherence phase: the synergic mechanism for successful colonization and disease development. Toxins (Basel) 13(7):485. https:\/\/doi.org\/10.3390\/toxins13070485","DOI":"10.3390\/toxins13070485"},{"key":"11134_CR41","doi-asserted-by":"publisher","first-page":"1038349","DOI":"10.3389\/fimmu.2022.1038349","volume":"13","author":"A Prichard","year":"2022","unstructured":"Prichard A, Khuu L, Whitmore LC, Irimia D, Allen LH (2022) Helicobacter pylori-infected human neutrophils exhibit impaired chemotaxis and a uropod retraction defect. Front Immunol 13:1038349","journal-title":"Front Immunol"},{"issue":"11","key":"11134_CR42","first-page":"e1878","volume":"6","author":"I Chattopadhyay","year":"2023","unstructured":"Chattopadhyay I, Gundamaraju R, Rajeev A (2023) Diversification and deleterious role of microbiome in gastric cancer. Cancer Rep (Hoboken) 6(11):e1878","journal-title":"Cancer Rep (Hoboken)"},{"key":"11134_CR43","doi-asserted-by":"publisher","first-page":"100009","DOI":"10.1016\/j.microb.2023.100009","volume":"1","author":"EM Appiah","year":"2023","unstructured":"Appiah EM, Yakubu B, Salifu SP (2023) Comprehensive microbial network analysis of gastric microbiome reveal key species affecting gastric carcinogenesis. Microbe 1:100009","journal-title":"Microbe"},{"issue":"5","key":"11134_CR44","doi-asserted-by":"publisher","first-page":"e28761","DOI":"10.1002\/jmv.28761","volume":"95","author":"Q Xu","year":"2023","unstructured":"Xu Q, Dong H, Wang Z, Zhang P, Albers AE, Kaufmann AM, Zheng Z-M, Qian X (2023) Integration and viral oncogene expression of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma and gastric cancer. J Med Virol 95(5):e28761","journal-title":"J Med Virol"},{"key":"11134_CR45","doi-asserted-by":"publisher","first-page":"889694","DOI":"10.3389\/fmicb.2022.889694","volume":"13","author":"P Yang","year":"2022","unstructured":"Yang P, Zhang X, Xu R, Adeel K, Lu X, Chen M, Shen H, Li Z, Xu Z (2022) Fungal Microbiota Dysbiosis and Ecological Alterations in Gastric Cancer. Front Microbiol 13:889694","journal-title":"Front Microbiol"},{"issue":"1","key":"11134_CR46","first-page":"6011632","volume":"2022","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Feng H, Qiu Y, Xu Z, Xie Q, Ding W, Liu H, Li G (2022) Dysbiosis of Gastric Mucosal Fungal Microbiota in the Gastric Cancer Microenvironment. J Immunol Res 2022(1):6011632","journal-title":"J Immunol Res"},{"issue":"04","key":"11134_CR47","doi-asserted-by":"publisher","first-page":"272","DOI":"10.21926\/obm.genet.2404272","volume":"08","author":"P Zeynali","year":"2024","unstructured":"Zeynali P, Teimouri H, Hashemi SMA, Ebrahimian A, Faraji SN, Sakhaei S, Behboudi E (2024) Epstein-Barr Virus and Helicobacter pylori as Two Main Risk Factors in Gastric Cancer. OBM Genet 08(04):272","journal-title":"OBM Genet"},{"issue":"1","key":"11134_CR48","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1038\/s41467-025-60999-5","volume":"16","author":"M-F Ji","year":"2025","unstructured":"Ji M-F, He Y-Q, Tang M-Z, Xue W-Q, Yu X, Diao H, Yang D-W, Mai Z-M, Cheong IH, Zhao Z-Y, Wu B-H, Li F-G, Zhan J-Y, Huang C-L, Ma H-L, Li J, Li Y-C, Wang T-M, Liao Y, Chen X-Y, Liang Z-H, Lian S-F, Du Y, Liang X-J, Kozlakidis Z, Ma J, Jia W-H (2025) Epstein Barr virus antibody and cancer risk in two prospective cohorts in Southern China. Nat Commun 16(1):5940","journal-title":"Nat Commun"},{"key":"11134_CR49","doi-asserted-by":"publisher","unstructured":"Park JY, Kang CS, Seo HC, Shin JC, Kym SM, Park YS, Shin TS, Kim JG, Kim YK (2021) Bacteria-derived extracellular vesicles in urine as a novel biomarker for gastric cancer: integration of liquid biopsy and metagenome analysis. Cancers (Basel) 13(18):4687. https:\/\/doi.org\/10.3390\/cancers13184687","DOI":"10.3390\/cancers13184687"},{"issue":"3","key":"11134_CR50","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/15384101.2024.2324587","volume":"23","author":"X Meng","year":"2024","unstructured":"Meng X, Ma G, Zhang X, Yin H, Miao Y, He F (2024) Extracellular vesicles from Fusobacterium nucleatum: roles in the malignant phenotypes of gastric cancer. Cell Cycle 23(3):294\u2013307","journal-title":"Cell Cycle"},{"issue":"1","key":"11134_CR51","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1038\/s41467-025-57633-9","volume":"16","author":"Y Li","year":"2025","unstructured":"Li Y, Fu B, Wang M, Chen W, Fan J, Li Y, Liu X, Wang J, Zhang Z, Lu H, Zhang Y (2025) Urinary extracellular vesicle N-glycomics identifies diagnostic glycosignatures for bladder cancer. Nat Commun 16(1):2292","journal-title":"Nat Commun"},{"issue":"18","key":"11134_CR52","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1111\/jcmm.17511","volume":"26","author":"M Kohansal","year":"2022","unstructured":"Kohansal M, Ghanbarisad A, Tabrizi R, Daraei A, Kashfi M, Tang H, Song C, Chen Y (2022) tRNA-derived fragments in gastric cancer: Biomarkers and functions. J Cell Mol Med 26(18):4768\u20134780","journal-title":"J Cell Mol Med"},{"issue":"7","key":"11134_CR53","doi-asserted-by":"publisher","first-page":"e0008924","DOI":"10.1128\/msystems.00089-24","volume":"9","author":"L Lei","year":"2024","unstructured":"Lei L, Zhao LY, Cheng R, Zhang H, Xia M, Chen XL, Kudriashov V, Liu K, Zhang WH, Jiang H, Chen Y, Zhu L, Zhou H, Yang K, Hu T, Hu JK (2024) Distinct oral-associated gastric microbiota and Helicobacter pylori communities for spatial microbial heterogeneity in gastric cancer. mSystems 9(7):e0008924","journal-title":"mSystems"},{"issue":"1","key":"11134_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41522-024-00623-4","volume":"11","author":"M Xia","year":"2025","unstructured":"Xia M, Lei L, Zhao L, Xu W, Zhang H, Li M, Hu J, Cheng R, Hu T (2025) The dynamic oral-gastric microbial axis connects oral and gastric health: current evidence and disputes. NPJ Biofilms Microbiomes 11(1):1","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"2","key":"11134_CR55","doi-asserted-by":"publisher","first-page":"e41715","DOI":"10.1016\/j.heliyon.2025.e41715","volume":"11","author":"X Feng","year":"2025","unstructured":"Feng X, Zhang Y, Feng J, Li Z, Zhang Z, Zhu L, Zhou R, Wang H, Dai X, Liu Y (2025) Exploring changes in metabolites and fecal microbiota of advanced gastric cancer based on plasma metabolomics and 16S rDNA sequencing. Heliyon 11(2):e41715","journal-title":"Heliyon"},{"issue":"1","key":"11134_CR56","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s13402-024-00965-3","volume":"48","author":"B Wang","year":"2025","unstructured":"Wang B, Luan J, Zhao W, Yu J, Li A, Li X, Zhong X, Cao H, Wang R, Liu B, Lu S, Shi M (2025) Comprehensive multiomics analysis of the signatures of gastric mucosal bacteria and plasma metabolites across different stomach microhabitats in the development of gastric cancer. Cell Oncol (Dordr) 48(1):139\u2013159","journal-title":"Cell Oncol (Dordr)"},{"key":"11134_CR57","doi-asserted-by":"publisher","first-page":"343264","DOI":"10.1016\/j.aca.2024.343264","volume":"1336","author":"R Fan","year":"2025","unstructured":"Fan R, Chen S, Lan F, Li W, Zhu Y, Zhang L, Zhang Y, Li L (2025) Surface-Enhanced Raman Scattering (SERS)-based biosensors for advanced extracellular vesicle detection: A review. Anal Chim Acta 1336:343264","journal-title":"Anal Chim Acta"},{"issue":"47","key":"11134_CR58","doi-asserted-by":"publisher","first-page":"20830","DOI":"10.1021\/acs.est.4c06737","volume":"58","author":"S Srivastava","year":"2024","unstructured":"Srivastava S, Wang W, Zhou W, Jin M, Vikesland PJ (2024) Machine Learning-Assisted Surface-Enhanced Raman Spectroscopy Detection for Environmental Applications: A Review. Environ Sci Technol 58(47):20830\u201320848","journal-title":"Environ Sci Technol"},{"issue":"8","key":"11134_CR59","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1136\/gutjnl-2024-333657","volume":"74","author":"X Guo","year":"2025","unstructured":"Guo X, Wang W, Cheng X, Song Q, Wang X, Wei J, Xu S, Lv X, Ji G (2025) Diagnostic efficacy of an extracellular vesicle-derived lncRNA-based liquid biopsy signature for the early detection of early-onset gastric cancer. Gut 74(8):1209\u20131218","journal-title":"Gut"},{"issue":"8\u20139","key":"11134_CR60","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/carcin\/bgad063","volume":"44","author":"H Zong","year":"2023","unstructured":"Zong H, Yu W, Lai H, Chen B, Zhang H, Zhao J, Huang S, Li Y (2023) Extracellular vesicles long RNA profiling identifies abundant mRNA, circRNA and lncRNA in human bile as potential biomarkers for cancer diagnosis. Carcinogenesis 44(8\u20139):671\u2013681","journal-title":"Carcinogenesis"},{"key":"11134_CR61","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/CMAR.S494747","volume":"17","author":"S Wang","year":"2025","unstructured":"Wang S, Ma C, Ren Z, Zhang Y, Hao K, Liu C, Xu L, He S, Zhang J (2025) Diagnostic Value of Glycosylated Extracellular Vesicle microRNAs in Gastric Cancer. Cancer Manag Res 17:145\u2013160","journal-title":"Cancer Manag Res"},{"issue":"1","key":"11134_CR62","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40164-023-00442-x","volume":"12","author":"M Zhang","year":"2023","unstructured":"Zhang M, Liu J, Xia Q (2023) Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target. Exp Hematol Oncol 12(1):84","journal-title":"Exp Hematol Oncol"},{"key":"11134_CR63","doi-asserted-by":"crossref","unstructured":"Marashi A, Hasany S, Moghimi S, Kiani R, Mehran Asl S, Dareghlou YA, Lorestani P, Varmazyar S, Jafari F, Ataeian S, Naghavi K, Sajjadi SM, Haratian N, Alinezhad A, Azhdarimoghaddam A, Sadat SK, Rafiei MA, Anar (2024) Targeting gut-microbiota for gastric cancer treatment: a systematic review. Front Med 11","DOI":"10.3389\/fmed.2024.1412709"},{"issue":"11","key":"11134_CR64","doi-asserted-by":"publisher","first-page":"101251","DOI":"10.1016\/j.xcrm.2023.101251","volume":"4","author":"CG Kim","year":"2023","unstructured":"Kim CG, Koh JY, Shin SJ, Shin JH, Hong M, Chung HC, Rha SY, Kim HS, Lee CK, Lee JH, Han Y, Kim H, Che X, Yun UJ, Kim H, Kim JH, Lee SY, Park SK, Park S, Kim H, Ahn JY, Jeung HC, Lee JS, Nam YD, Jung M (2023) Prior antibiotic administration disrupts anti-PD-1 responses in advanced gastric cancer by altering the gut microbiome and systemic immune response. Cell Rep Med 4(11):101251","journal-title":"Cell Rep Med"},{"issue":"7","key":"11134_CR65","doi-asserted-by":"publisher","first-page":"e1312","DOI":"10.1002\/ctm2.1312","volume":"13","author":"Z Han","year":"2023","unstructured":"Han Z, Cheng S, Dai D, Kou Y, Zhang X, Li F, Yin X, Ji J, Zhang Z, Wang X, Zhu N, Zhang Q, Tan Y, Guo X, Shen L, Peng Z (2023) The gut microbiome affects response of treatments in HER2-negative advanced gastric cancer. Clin Transl Med 13(7):e1312","journal-title":"Clin Transl Med"},{"key":"11134_CR66","doi-asserted-by":"publisher","first-page":"100340","DOI":"10.1016\/j.crbiot.2025.100340","volume":"10","author":"Z Seyyedi","year":"2025","unstructured":"Seyyedi Z, Haddad Kashani H, Parchebafi A, Ghayoumi R, Haghighat Lari MM, Hosseini ES (2025) Integrating probiotics and microbiome-derived metabolites into cancer therapy: mechanistic insights, multi-omics strategies, and clinical potential. Curr Res Biotechnol 10:100340","journal-title":"Curr Res Biotechnol"},{"issue":"1","key":"11134_CR67","doi-asserted-by":"publisher","first-page":"2300846","DOI":"10.1080\/19490976.2023.2300846","volume":"16","author":"SY Lee","year":"2024","unstructured":"Lee SY, Jhun J, Woo JS, Lee KH, Hwang SH, Moon J, Park G, Choi SS, Kim SJ, Jung YJ, Song KY, Cho ML (2024) Gut microbiome-derived butyrate inhibits the immunosuppressive factors PD-L1 and IL-10 in tumor-associated macrophages in gastric cancer. Gut Microbes 16(1):2300846","journal-title":"Gut Microbes"},{"issue":"4","key":"11134_CR68","doi-asserted-by":"publisher","first-page":"e202895","DOI":"10.1001\/jamanetworkopen.2020.2895","volume":"3","author":"M Nomura","year":"2020","unstructured":"Nomura M, Nagatomo R, Doi K, Shimizu J, Baba K, Saito T, Matsumoto S, Inoue K, Muto M (2020) Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors. JAMA Netw Open 3(4):e202895\u2013e202895","journal-title":"JAMA Netw Open"},{"issue":"8","key":"11134_CR69","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.chom.2024.06.010","volume":"32","author":"Y Kim","year":"2024","unstructured":"Kim Y, Kim G, Kim S, Cho B, Kim SY, Do EJ, Bae DJ, Kim S, Kweon MN, Song JS, Park SH, Hwang SW, Kim MN, Kim Y, Min K, Kim SH, Adams MD, Lee C, Park H, Park SR (2024) Fecal microbiota transplantation improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers refractory to anti-PD-1 inhibitor. Cell Host Microbe 32(8):1380\u20131393e9","journal-title":"Cell Host Microbe"},{"issue":"4suppl","key":"11134_CR70","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1200\/JCO.2023.41.4_suppl.389","volume":"41","author":"Z Peng","year":"2023","unstructured":"Peng Z, Zhang X, Xie T, Cheng S, Han Z, Wang S, Ban Z, Xu X, Zhu Z, Zhu J, Yin X, Li S, Shen L (2023) Efficacy of fecal microbiota transplantation in patients with anti-PD-1\u2013resistant\/refractory gastrointestinal cancers. J Clin Oncol 41(4suppl):389\u2013389","journal-title":"J Clin Oncol"},{"key":"11134_CR71","doi-asserted-by":"publisher","unstructured":"Chalif J, Morton M, Haight P, Mehra Y, O\u2019Malley D, Spakowicz D, Chambers L Assessment of probiotic and prebiotic use in gynecologic cancer patients: a systematic review. Am J Obstetr Gynecol 234(4):893\u2013918. https:\/\/doi.org\/10.1016\/j.ajog.2025.09.042","DOI":"10.1016\/j.ajog.2025.09.042"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11134-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-026-11134-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-026-11134-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:04:18Z","timestamp":1789380258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-026-11134-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":71,"alternative-id":["11134"],"URL":"https:\/\/doi.org\/10.1007\/s12602-026-11134-3","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}